Company news

Shanghai Haohai Biological Technology Co., Ltd. news in 2026

Shanghai Haohai Biological Technology Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(688366)"Shanghai Haohai Biological Technology Co., Ltd."Announcement on Use of Temporarily Idle Raised Funds for Cash Management

November 2, 2026

(688366)"Shanghai Haohai Biological Technology Co., Ltd."Report for Q3 2026

October 23, 2026

Announcement on Adjustment of the Total Cash Dividend Amount for the 2026 Semi-annual Profit Distribution

September 13, 2026

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry

September 7, 2026

Announcement on the Profit Distribution Plan for the First Half of 2026

August 21, 2026

Announcement on Voluntary Disclosure of Obtaining Medical Device Registration Certificate for Trifocal Toric Intraocular Lens Product of the Controlled Subsidiary

August 6, 2026

Announcement on the Cancellation of Repurchased H Shares

June 22, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 10, 2026

Announcement on Voluntary Disclosure of the Holding Subsidiary’s Trifocal Intraocular Lens Product Obtaining the Medical Device Registration Certificate

June 2, 2026

Announcement on Adjusting the Total Cash Dividends for the 2025 Annual Profit Distribution

June 1, 2026

Announcement on Notifying Creditors in Connection with the Repurchase of H-share Stocks

May 29, 2026

Announcement on Result of Shareholding Reduction by Shareholder

May 25, 2026

Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference

April 30, 2026

Notice on Convening the 2025 Annual General Meeting, the 1st Shareholders' Meeting of A Shares of 2026 and the 1st Shareholders' Meeting of H Shares of 2026

April 28, 2026

Report for Q1 2026

April 24, 2026

Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Multifocal Aspherical Intraocular Lens Product Obtaining the Medical Device Registration Certificate

April 7, 2026

Announcement on Provision for Asset Impairment for 2025

March 20, 2026

Announcement on Voluntary Disclosure of the Wholly-owned Subsidiary’s Intraocular Crosslinked Sodium Hyaluronate Gel Product Obtaining the Medical Device Registration Certificate

March 16, 2026

Announcement on Preliminary Earnings Estimate for 2025

February 27, 2026

Announcement on Shareholding Reduction Plan for Shareholders

February 12, 2026